Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-067430

Chief Technical Officer sold 7,969 shares at an average $77.78 ($619,851)

  • Chief Technical Officer acquired 7,969 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shulman Joseph Chief Technical Officer 2025-07-09 Option exercise 10b5-1 +7,969 $6.80 $54,189 16,478 D
Shulman Joseph Chief Technical Officer 2025-07-09 Sale 10b5-1 −3,984 $75.56 $301,051 12,494 D
Shulman Joseph Chief Technical Officer 2025-07-09 Sale 10b5-1 −3,985 $80.00 $318,800 8,509 D
Derivatives
Shulman Joseph Chief Technical Officer 2025-07-09 Option exercise · Stock Options (Right to Buy) 10b5-1 −7,969 11,953 D
Open-market sales · 7,969 sh · avg $77.78 · $619,851
Loading xslF345X05/tm2520691-3_4seq1.xml…